Douglas M. Fambrough, III
2016
In 2016, Douglas M. Fambrough, III earned a total compensation of $2M as President and Chief Executive Officer at Dicerna Pharmaceuticals, a 40% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $179,084 |
|---|---|
| Option Awards | $1,317,888 |
| Salary | $490,000 |
| Other | $18,142 |
| Total | $2,005,115 |
Fambrough received $1.3M in option awards, accounting for 66% of the total pay in 2016.
Fambrough also received $179.1K in non-equity incentive plan, $490K in salary and $18.1K in other compensation.
Rankings
In 2016, Douglas M. Fambrough, III's compensation ranked 4,876th out of 14,075 executives tracked by ExecPay. In other words, Fambrough earned more than 65.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,876 out of 14,075 | 65th |
Division Manufacturing | 1,735 out of 5,489 | 68th |
Major group Chemicals And Allied Products | 544 out of 1,895 | 71st |
Industry group Drugs | 400 out of 1,538 | 74th |
Industry Pharmaceutical Preparations | 318 out of 1,176 | 73rd |
Source: SEC filing on May 23, 2017.
Fambrough's colleagues
We found two more compensation records of executives who worked with Douglas M. Fambrough, III at Dicerna Pharmaceuticals in 2016.